載入...
Paclitaxel as Albumin-Bound Nanoparticles with Gemcitabine for Untreated Metastatic Pancreatic Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal
As part of the single technology appraisal (STA) process, the National Institute for Health and Care Excellence (NICE) invited Celgene Ltd to submit clinical and cost-effectiveness evidence for paclitaxel as albumin-bound nanoparticles (Nab-Pac) in combination with gemcitabine (Nab-Pac + Gem) for pa...
Na minha lista:
| 發表在: | Pharmacoeconomics |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6132498/ https://ncbi.nlm.nih.gov/pubmed/29600384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40273-018-0646-1 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|